<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01989312</url>
  </required_header>
  <id_info>
    <org_study_id>03-99-12</org_study_id>
    <nct_id>NCT01989312</nct_id>
  </id_info>
  <brief_title>The Simultaneous Use of Supraclavicular and Distal Blocks</brief_title>
  <official_title>Can we Gain an Advantage by Combining Distal Median, Radial and Ulnar Nerve Blocks With Supraclavicular Block? A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the combined ultrasound-guided supraclavicular brachial
      plexus block and distal median, radial, and ulnar nerve blocks, with supraclavicular block
      alone.

      Sixty two patients undergoing upper extremity surgery will be randomized to supraclavicular
      only (Group S, n=31) or supraclavicular + distal (Group SD, n=31) group. Patients in group S
      will receive 32 mL of lidocaine 1.5% + epinephrine 5µg/mL and in group SD receive 20 mL of
      lidocaine 1.5% + epinephrine 5µg/mL followed by a distal median, radial, and ulnar nerve
      blocks using 50:50 mixture of lidocaine 2% + levobupivacaine 0.5% (4 mL/nerve). Sensory and
      motor block of the ulnar, median, radial and musculocutaneous nerves will be assessed every 5
      minutes starting at the 10th minutes. The imaging, needling and performance times will be
      recorded. Also the onset and anesthesia related times, need for analgesic and first analgesic
      time will be noted.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The time required after a supraclavicular block alone or a supraclavicular block combined with distal blocks, to achieve a sensory and motor block needed for surgery.</measure>
    <time_frame>All patients will be followed up during the block procedure and during the surgery. Also, after the surgery patients will be followed up to 7 days postoperatively.</time_frame>
    <description>The onset time of supraclavicular plexus block and the onset time of supraclavicular block combined with distal median, radial, and ulnar nerve blocks will be followed up. The time needed to achieve a surgical block will be assessed in both groups. The difference between the 2 groups will be compared and analysed. For this an investigator blinded to the group allocation will evaluate the sensorial pinprick and motor blocks of the ulnar, median, radial and musculocutaneous nerves every 5 minutes starting at the 10th minutes until 30th minutes.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Orthopaedic Disorders</condition>
  <condition>Nerve Block</condition>
  <condition>Anaesthesia</condition>
  <arm_group>
    <arm_group_label>supraclavicular block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A supraclavicular block with 32 mL of lidocaine 1.5% + epinephrine 5µg/mL was performed for the anaesthetic management of the forearm and hand.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supraclavicular and median, ulnar, radial blocks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group received 20 mL of lidocaine 1.5% + epinephrine 5µg/mL for supraclavicular block and after the supraclavicular block they recieved a distal median, radial, and ulnar nerve blocks using 50:50 mixture of lidocaine 2% + levobupivacaine 0.5% (4 mL/nerve).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intravenous cannulation.</intervention_name>
    <description>A 18-or 20-gauge intravenous (iv) catheter was placed to the contralateral arm according to the surgical site</description>
    <arm_group_label>supraclavicular block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Supraclavicular block and ultrasound-guided ulnar, median and radial nerve blocks.</intervention_name>
    <description>Supraclavicular block with 20 mL of lidocaine 1.5% + epinephrine 5µg/mL and the addition of ultrasound-guided ulnar, median and radial nerve blocks. For that 12 mL of local anesthetic solution of a 50:50 mixture of lidocaine 2% and levobupivacaine 0.5% (4 mL/nerve) was used.</description>
    <arm_group_label>Supraclavicular and median, ulnar, radial blocks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intravenous cannulation.</intervention_name>
    <description>A 18-or 20-gauge intravenous (iv) catheter was placed to the contralateral arm according to the surgical site</description>
    <arm_group_label>supraclavicular block</arm_group_label>
    <arm_group_label>Supraclavicular and median, ulnar, radial blocks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Routine ASA monitoring</intervention_name>
    <description>Monitorization with ECG, noninvasive blood pressure and spO2.</description>
    <arm_group_label>supraclavicular block</arm_group_label>
    <arm_group_label>Supraclavicular and median, ulnar, radial blocks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Premedication midazolam</intervention_name>
    <description>Premedication with 0.03 mg/kg midazolam iv</description>
    <arm_group_label>supraclavicular block</arm_group_label>
    <arm_group_label>Supraclavicular and median, ulnar, radial blocks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <arm_group_label>supraclavicular block</arm_group_label>
    <arm_group_label>Supraclavicular and median, ulnar, radial blocks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine</intervention_name>
    <arm_group_label>supraclavicular block</arm_group_label>
    <arm_group_label>Supraclavicular and median, ulnar, radial blocks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <arm_group_label>Supraclavicular and median, ulnar, radial blocks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 and 80 years old patient

          -  American Society of Anesthesiologists (ASA) physical status I-III

          -  Scheduled for elective hand and forearm surgery

        Exclusion Criteria:

          -  patient refusal

          -  preexisting neuropathy

          -  coagulopathy

          -  allergy to agents used

          -  pregnancy

          -  body mass index &gt; 35 kg/m2

          -  chronic obstructive pulmonary disease

          -  infection or previous surgery in the supraclavicular area

          -  systemic infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Basak Ceyda Meco, MD, DESA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ankara University Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ankara University Faculty of Medicine, Ibni Sina Hospital colonoscopy lab</name>
      <address>
        <city>Ankara</city>
        <zip>06700</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2013</study_first_submitted>
  <study_first_submitted_qc>November 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2013</study_first_posted>
  <last_update_submitted>November 20, 2013</last_update_submitted>
  <last_update_submitted_qc>November 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara University</investigator_affiliation>
    <investigator_full_name>Basak Ceyda MECO</investigator_full_name>
    <investigator_title>MD,DESA</investigator_title>
  </responsible_party>
  <keyword>ultrasound</keyword>
  <keyword>peripheral nerves</keyword>
  <keyword>anesthetics</keyword>
  <keyword>local</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>January 9, 2014</submitted>
    <returned>February 25, 2014</returned>
    <submitted>April 1, 2014</submitted>
    <returned>May 1, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

